• 72+ member team in 12 major business and technology centersin the US, Europe and Asia and GCC ( Emirates)

 

• Broad industry platform with clients across many industries andsophisticated capabilities in all practice areas

 

• Excel in deals in the tech, Crypto, Investment Funds extructure ,life sciences, medical device and healthcare, consumer,education, defense and media industries

 

• Given our market position in the medtech and life sciencessectors, we have handled a large number of life sciences M&A transactions, both public and private, and understand uniquestructuring issues for life sciences companies, includingmilestone structures, contingent value rights and optionstructures

 

• Primary corporate counsel to 100+ public and privatescompanies, giving us an unmatched perspective on market dealpoints and ability to facilitate introductions between buyers andsellers

 

• Represent all categories of participants in transactions, includingbuyers, sellers, major stockholders, venture capitalists, lenders,financial advisors, management/founders, special boardcommittees, individual investors, private equity funds, hedgefunds and others

 

 • Adept at handling all manner of transactions, including domesticand cross-border mergers and acquisitions, strategic dealsincluding joint ventures, acquisitions of IP assets, patent cross-licenses, complex divestitures and spin-offs, takeover defenseand shareholder activism counseling, and multibillion-dollarpublic company mergers

 

• Robust SPAC experience and thought leaders in the area with arepository of market insight and guidance for businessesinterested in the IPO alternative .

 

• Market-leading IP, privacy, technology licensing, life sciencescollaborations and licensing, regulatory, government contracts,credit finance, private equity, antitrust, employment,compensation and tax practices to support transactions